However, in oestrogen receptor alpha positive breast cancer cell lines MCF7 and T47D, BCL9L promotes tumourigenicity independent of Wnt/β-catenin signalling, but through induction of the oestrogen receptor alpha signalling [32]. Here, BCL9L is linked to breast cancer.